CAP Cancer Protocol Pharynx
Protocol for the Examination of Specimens From Patients With Cancers of the Pharynx Version: Pharynx 4.0.0.2Protocol Posting Date: February 2019Includes pTNM requirements from the 8th Edition, AJCC Staging ManualFor accreditation purposes, this protocol should be used for the following procedures AND tumor types: ProcedureDescriptionResectionIncludes specimens designated pharynx (oropharynx, nasopharynx, hypopharynx) including the base of the tongue, tonsils, soft palate, and uvulaTumor TypeDescriptionCarcinomaIncludes squamous cell carcinoma, neuroendocrine carcinoma, and minor salivary gland carcinomaMucosal MelanomaThis protocol is NOT required for accreditation purposes for the following:ProcedureBiopsyPrimary resection specimen with no residual cancer (eg, following neoadjuvant therapy)Cytologic specimensThe following tumor types should NOT be reported using this protocol:Tumor TypeSarcoma (consider the Soft Tissue protocol)Lymphoma (consider the Hodgkin or non-Hodgkin Lymphoma protocols)AuthorsRaja R. Seethala, MD*; Ilan Weinreb, MD*; Martin J. Bullock, MD; Diane L. Carlson, MD; Robert L. Ferris, MD, PhD; Louis B. Harrison, MD; Jonathan B. McHugh, MD; Jason Pettus, MD; Mary S. Richardson, MD; Jatin Shah, MD; Lester D.R. Thompson, MD; Bruce M. Wenig, MDWith guidance from the CAP Cancer and CAP Pathology Electronic Reporting Committees.* Denotes primary author. All other contributing authors are listed alphabetically.Accreditation RequirementsThis protocol can be utilized for a variety of procedures and tumor types for clinical care purposes. For accreditation purposes, only the definitive primary cancer resection specimen is required to have the core and conditional data elements reported in a synoptic format. Core data elements are required in reports to adequately describe appropriate malignancies. For accreditation purposes, essential data elements must be reported in all instances, even if the response is “not applicable” or “cannot be determined.”Conditional data elements are only required to be reported if applicable as delineated in the protocol. For instance, the total number of lymph nodes examined must be reported, but only if nodes are present in the specimen.Optional data elements are identified with “+” and although not required for CAP accreditation purposes, may be considered for reporting as determined by local practice standards.The use of this protocol is not required for recurrent tumors or for metastatic tumors that are resected at a different time than the primary tumor. Use of this protocol is also not required for pathology reviews performed at a second institution (ie, secondary consultation, second opinion, or review of outside case at second institution).Synoptic ReportingAll core and conditionally required data elements outlined on the surgical case summary from this cancer protocol must be displayed in synoptic report format. Synoptic format is defined as:Data element: followed by its answer (response), outline format without the paired "Data element: Response" format is NOT considered synoptic.The data element should be represented in the report as it is listed in the case summary. The response for any data element may be modified from those listed in the case summary, including “Cannot be determined” if appropriate. Each diagnostic parameter pair (Data element: Response) is listed on a separate line or in a tabular format to achieve visual separation. The following exceptions are allowed to be listed on one line:Anatomic site or specimen, laterality, and procedurePathologic Stage Classification (pTNM) elementsNegative margins, as long as all negative margins are specifically enumerated where applicableThe synoptic portion of the report can appear in the diagnosis section of the pathology report, at the end of the report or in a separate section, but all Data element: Responses must be listed together in one locationOrganizations and pathologists may choose to list the required elements in any order, use additional methods in order to enhance or achieve visual separation, or add optional items within the synoptic report. The report may have required elements in a summary format elsewhere in the report IN ADDITION TO but not as replacement for the synoptic report ie, all required elements must be in the synoptic portion of the report in the format defined above.CAP Laboratory Accreditation Program Protocol Required Use Date: March 2018CAP Pharynx Protocol Summary of ChangesVersion 4.0.0.2Added note to Ancillary Studies to provide guidance on reporting staging categories when HPV status is unknown.Surgical Pathology Cancer Case SummaryProtocol posting date: February 2019PHARYNX (OROPHARYNX, HYPOPHARYNX, NASOPHARYNX): Select a single response unless otherwise indicated.Procedure (select all that apply)___ Excision___ Tonsillectomy___ Laryngopharyngectomy___ Neck (lymph node) dissection (specify): _______________________________ Other (specify): _______________________________ Not specifiedTumor Site (Note A)#___Oropharynx+ ___ Palatine tonsil+ ___ Base of tongue, including lingual tonsil+ ___ Soft palate+ ___ Uvula? + ___ Pharyngeal wall (posterior)___ Nasopharynx+___ Nasopharyngeal tonsils (adenoids)___ Hypopharynx+___ Piriform sinus+___ Postcricoid+___ Pharyngeal wall (posterior and/or lateral)___ Other (specify): _______________________________ Not specified# Note: Multiple subsites may be selected.Tumor Laterality (select all that apply)___ Left___ Right___ Midline___ Not specified Tumor Focality___ Unifocal___ Multifocal___ Cannot be determinedTumor SizeGreatest dimension (centimeters): ___ cm+ Additional dimensions (centimeters): ___ x ___ cm___ Cannot be determined (explain): ______________________________Histologic Type (Notes B and C)Carcinomas of the Oropharynx and Hypopharynx___ Human papillomavirus (HPV)-mediated (positive) squamous cell carcinoma (oropharynx only)___ HPV-unrelated (negative) squamous cell carcinoma (oropharynx)___ Oropharyngeal squamous cell carcinoma, HPV status unknown (see “ancillary studies” for additional notes) ___ Hypopharyngeal squamous cell carcinomaSquamous Cell Carcinoma and Variants (select all that apply)___ Squamous cell carcinoma, conventional (keratinizing)___ Squamous cell carcinoma, nonkeratinizing___ Acantholytic squamous cell carcinoma___ Adenosquamous carcinoma___ Basaloid squamous cell carcinoma___ Papillary squamous cell carcinoma___ Spindle cell squamous cell carcinoma___ Verrucous squamous cell carcinoma___ Lymphoepithelial carcinoma (non-nasopharyngeal)Carcinomas of the Nasopharynx___ Keratinizing squamous cell carcinoma___ Nonkeratinizing squamous cell carcinoma ___ Basaloid squamous cell carcinoma Carcinomas of Minor Salivary Glands ___ Mucoepidermoid carcinoma, low grade___ Mucoepidermoid carcinoma, intermediate grade___ Mucoepidermoid carcinoma, high grade___ Adenoid cystic carcinoma, tubular pattern#+ Specify percentage of solid component: ____%___ Adenoid cystic carcinoma, cribriform pattern#+ Specify percentage of solid component: ____%___ Adenoid cystic carcinoma, solid pattern#+ Specify percentage of solid component: ____%___ Acinic cell carcinoma___ Polymorphous adenocarcinoma, classic, low grade___ Polymorphous adenocarcinoma, classic, intermediate grade___ Polymorphous adenocarcinoma, classic, high grade___ Polymorphous adenocarcinoma, cribriform (cribriform adenocarcinoma of salivary origin), low grade___ Polymorphous adenocarcinoma, cribriform (cribriform adenocarcinoma of salivary origin), intermediate grade___ Polymorphous adenocarcinoma, cribriform (cribriform adenocarcinoma of salivary origin), high grade___ (Mammary analogue) Secretory carcinoma___ Salivary duct carcinoma___ Epithelial-myoepithelial carcinoma___ (Hyalinizing) clear cell carcinoma___ Adenocarcinoma, not otherwise specified, low grade___ Adenocarcinoma, not otherwise specified, intermediate grade___ Adenocarcinoma, not otherwise specified, high grade___ Basal cell adenocarcinoma___ Carcinosarcoma (true malignant mixed tumor)___ Intraductal carcinoma, low grade___ Intraductal carcinoma, high grade___ Lymphoepithelial carcinoma___ Myoepithelial carcinoma ___ Oncocytic carcinomaPreexisting pleomorphic adenoma component (required in addition to salivary carcinoma type, if applicable)___ Carcinoma ex pleomorphic adenoma, minimally invasive___ Carcinoma ex pleomorphic adenoma, invasive___ Carcinoma ex pleomorphic adenoma, intracapsular (noninvasive)# Note: If multiple patterns present, select predominant pattern unless solid pattern is greater than 30%, in which case should select solid patternAdenocarcinomas (Non-Salivary Gland Type)___ Nasopharyngeal papillary adenocarcinomaNeuroendocrine Carcinoma___ Small cell neuroendocrine carcinoma, HPV negative___ Small cell neuroendocrine carcinoma, HPV positive___ Large cell neuroendocrine carcinoma, HPV negative___ Large cell neuroendocrine carcinoma, HPV positive___ Mucosal melanoma___ Carcinoma, type cannot be determined___ Other histologic type not listed (specify): ___________________________Histologic Grade (Note C) (required for squamous cell carcinomas [HPV-unrelated/negative) only])___ G1: Well differentiated___ G2: Moderately differentiated___ G3: Poorly differentiated___ Other (specify): _______________________________ GX: Cannot be assessed+ Tumor Extension+ Specify: ____________________________Margins (select all that apply) (Notes D and E)___ Cannot be assessed___ Uninvolved by invasive tumorDistance from closest margin (millimeters): ____ mmSpecify location of closest margin, per orientation, if possible: ____________________________+ Location and distance of other close margins: _______________________________ Involved by invasive tumorSpecify margin(s), per orientation, if possible: _______________________________ Uninvolved by high-grade dysplasia/in situ disease #Distance from closest margin (millimeters): ____ mmSpecify location of closest margin, per orientation, if possible: _______________________________ Involved by high-grade dysplasia/in situ disease #Specify margin(s), per orientation, if possible: ____________________________# Note: Applicable only to nonoropharyngeal and HPV-negative oropharyngeal squamous cell carcinoma and histologic variants, and required only if margins uninvolved by invasive carcinoma.Lymphovascular Invasion___ Not identified___ Present___ Cannot be determinedPerineural Invasion (Note F)___ Not identified___ Present___ Cannot be determined Regional Lymph Nodes (Note G)___ No lymph nodes submitted or foundLymph Node Examination (required only if lymph nodes present in specimen)Number of Lymph Nodes Involved: ________Number of Lymph Nodes Examined: _______Lymph Node Metastasis Specific Characteristics (required for all histologies except mucosal melanoma, and only if lymph nodes involved)Laterality of Lymph Nodes Involved___ Ipsilateral (including midline)___ Contralateral___ Bilateral___ Cannot be determinedSize of Largest Metastatic Deposit (centimeters): ____ cm Extranodal Extension (ENE) (required only for HPV-unrelated/negative oropharyngeal and hypopharyngeal carcinomas) ___ Not identified ___ Present+ Distance from lymph node capsule (millimeters): _____ mm+ ___ ENEma (greater than 2 mm)+ ___ ENEmi (less than or equal to 2 mm)___ Cannot be determinedPathologic Stage Classification (pTNM, AJCC 8th Edition) (Note H)Note: Reporting of pT, pN, and (when applicable) pM categories is based on information available to the pathologist at the time the report is issued. Only the applicable T, N, or M category is required for reporting; their definitions need not be included in the report. The categories (with modifiers when applicable) can be listed on 1 line or more than 1 line.TNM Descriptors (required only if applicable) (select all that apply)___ m (multiple primary tumors)___ r (recurrent)___ y (posttreatment)For All Carcinomas Primary Tumor (pT) For HPV-Mediated (Positive) Oropharynx___ pT0:No primary identified ___ pT1:Tumor 2 cm or smaller in greatest dimension___ pT2:Tumor larger than 2 cm but not larger than 4 cm in greatest dimension ___ pT3:Tumor more than 4 cm in greatest dimension or extension to lingual surface of epiglottis___ pT4:Moderately advanced local disease. Tumor invades larynx, extrinsic muscle of tongue, medial pterygoid muscles, hard palate, or mandible or beyond ## Note: Mucosal extension to lingual surface of epiglottis from primary tumors of the base of the tongue and vallecula does not constitute invasion of larynx.For HPV-Unrelated (Negative) Oropharynx___ pTX: Primary tumor cannot be assessed___ pTis: Carcinoma in situ___ pT1:Tumor 2 cm or smaller in greatest dimension___ pT2:Tumor larger than 2 cm but not larger than 4 cm in greatest dimension___ pT3:Tumor larger than 4 cm in greatest dimension or extension to lingual surface of epiglottis___ pT4:Moderately advanced or very advanced local disease___ pT4a:Moderately advanced local disease. Tumor invades the larynx, extrinsic muscle of tongue, medial pterygoid, hard palate, or mandible#___ pT4b: Very advanced local disease. Tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, or skull base or encases carotid arteryFor Nasopharynx___ pTX:Primary tumor cannot be assessed___ pT0:No tumor identified, but EBV-positive cervical node(s) involvement ___ pT1:Tumor confined to nasopharynx, or extension to oropharynx and/or nasal cavity without parapharyngeal involvement___ pT2:Tumor with extension to parapharyngeal space, and/or adjacent soft tissue involvement (medial pterygoid, lateral pterygoid, prevertebral muscles)___ pT3:Tumor with infiltration of bony structures at skull base, cervical vertebra, pterygoid structures, and/or paranasal sinuses ___ pT4: Tumor with intracranial extension, involvement of cranial nerves, hypopharynx, orbit, parotid gland, and/or extensive soft tissue infiltration beyond the lateral surface of the lateral pterygoid muscleFor Hypopharynx ___ pTX:Primary tumor cannot be assessed___ pTis:Carcinoma in situ___ pT1:Tumor limited to one subsite of hypopharynx and/or 2 cm or smaller in greatest dimension___ pT2:Tumor invades more than one subsite of hypopharynx or an adjacent site, or measures larger than 2 cm but not larger than 4 cm in greatest dimension without fixation of hemilarynx___ pT3:Tumor measures larger than 4 cm in greatest dimension or with fixation of hemilarynx or extension to esophageal mucosa.___ pT4:Moderately advanced and very advanced local disease___ pT4a:Moderately advanced local disease. Tumor invades thyroid/cricoid cartilage, hyoid bone, thyroid gland, esophageal muscle or central compartment soft tissue.___ pT4b:Very advanced local disease. Tumor invades prevertebral fascia, encases carotid artery, or involves mediastinal structures. Regional Lymph Nodes (pN) (Note G)For HPV-Mediated (Positive) Oropharynx ___ pNX: Regional lymph nodes cannot be assessed___ pN0: No regional lymph node metastasis___ pN1: Metastasis in 4 or fewer lymph nodes___ pN2: Metastasis in more than 4 lymph nodesFor HPV-Unrelated (Negative) Oropharynx and Hypopharynx#___ pNX:Regional lymph nodes cannot be assessed___ pN0:No regional lymph node metastasis___ pN1: Metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE(?)___ pN2: Metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE(+); or larger than 3 cm but not larger than 6 cm in greatest dimension and ENE(?); or metastases in multiple ipsilateral lymph nodes, none larger than 6 cm in greatest dimension and ENE(?); or in bilateral or contralateral lymph node(s), none larger than 6 cm in greatest dimension and ENE(?)___ pN2a: Metastasis in single ipsilateral node 3 cm or smaller in greatest dimension and ENE(+); or a single ipsilateral node larger than 3 cm but not larger than 6 cm in greatest dimension and ENE(?)___ pN2b: Metastases in multiple ipsilateral nodes, none larger than 6 cm in greatest dimension and ENE(?)___ pN2c: Metastases in bilateral or contralateral lymph node(s), none larger than 6 cm in greatest dimension and ENE(?)___ pN3:Metastasis in a lymph node larger than 6 cm in greatest dimension and ENE(?); or in a single ipsilateral node larger than 3 cm in greatest dimension and ENE(+);or multiple ipsilateral, contralateral or bilateral nodes, any with ENE(+);or a single contralateral node of any size and ENE(+)___ pN3a: Metastasis in a lymph node larger than 6 cm in greatest dimension and ENE(?)___ pN3b: Metastasis in a single ipsilateral node larger than 3 cm in greatest dimension and ENE(+); or multiple ipsilateral, contralateral or bilateral nodes any with ENE(+);or a single contralateral node of any size and ENE(+)# Midline nodes are considered ipsilateral nodes.Note: Pathological ENE should be recorded as ENE(?) or ENE(+).Note: Measurement of the metastatic focus in the lymph nodes is based on the largest metastatic deposit size, which may include matted or fused lymph nodes.For Nasopharynx ___ pNX: Regional lymph nodes cannot be assessed___ pN0: No regional lymph node metastasis___ pN1: Unilateral metastasis in cervical lymph node(s) and/or unilateral or bilateral metastasis in retropharyngeal lymph node(s), 6 cm or smaller in greatest dimension, above the caudal border of cricoid cartilage___ pN2: Bilateral metastasis in cervical lymph node(s), 6 cm or smaller in greatest dimension, above the caudal border of cricoid cartilage ___ pN3:Unilateral or bilateral metastasis in cervical lymph node(s), larger than 6 cm in greatest dimension, and/or extension below the caudal border of cricoid cartilage Distant Metastasis (pM) (required only if confirmed pathologically in this case)___ pM1: Distant metastasisSpecify site(s), if known: ____________________________For Mucosal MelanomaPrimary Tumor (pT)___pT3:Tumors limited to the mucosa and immediately underlying soft tissue, regardless of thickness or greatest dimension; for example, polypoid nasal disease, pigmented or nonpigmented lesions of the oral cavity, pharynx, or larynx___pT4: Moderately advanced or very advanced disease___pT4a:Moderately advanced disease. Tumor involving deep soft tissue, cartilage, bone, or overlying skin. ___pT4b:Very advanced disease. Tumor involving brain, dura, skull base, lower cranial nerves (IX, X, XI, XII), masticator space, carotid artery, prevertebral space, or mediastinal structures.Regional Lymph Nodes (pN)___pNX:Regional lymph nodes cannot be assessed___pN0:No regional lymph node metastases___pN1:Regional lymph node metastases presentDistant Metastasis (pM) (required only if confirmed pathologically in this case) ___ pM1: Distant metastasis presentSpecify site(s), if known: ____________________________+ Additional Pathologic Findings (select all that apply) (Note I)+ ___ None identified+ ___ Keratinizing dysplasia, mild#+ ___ Keratinizing dysplasia, moderate#+ ___ Keratinizing dysplasia, severe (carcinoma in situ)#+ ___ Nonkeratinizing dysplasia, mild#+ ___ Nonkeratinizing dysplasia, moderate#+ ___ Nonkeratinizing dysplasia, severe (carcinoma in situ)#+ ___ Inflammation (specify type): ____________________________+ ___ Squamous metaplasia+ ___ Epithelial hyperplasia+ ___ Colonization, fungal+ ___ Colonization, bacterial+ ___ Other (specify): ____________________________# Note: Applicable only to nonoropharyngeal and HPV-negative oropharyngeal squamous cell carcinoma and histologic variants, and required only if margins uninvolved by invasive carcinoma.Ancillary Studies (if applicable) Note: For reporting molecular testing and other cancer biomarker testing results, the CAP Head and Neck Biomarker Template should be used. Pending biomarker studies should be listed in the Comments section of this report. Note that some form of high risk HPV testing is required for staging of oropharyngeal squamous cell carcinoma, and p16 immunohistochemistry is acceptable as a surrogate marker of HPV status in oropharynx.Note: It is highly recommended to perform p16 or other form of HPV testing prior to submitting the pT and pN sections of the synoptic checklist rather than listing the status as pending. Using the “Oropharyngeal squamous cell carcinoma, HPV status unknown” option simply because of a lack of access to these tests is highly discouraged. A consultation to another testing center prior to sign out is highly advised in order to use the correct staging system. In the event of an equivocal p16 or HPV test, or insufficient remaining tissue, the use of “Oropharyngeal squamous cell carcinoma, HPV status unknown” is appropriate. The recommendation in these instances is to test a separate sample, if available, and otherwise the staging system defaults to the HPV negative pT and pN criteria (although the tumor should NOT be labeled HPV negative). + Comment(s)Explanatory NotesScope of GuidelinesThe reporting of pharynx cancer including the lip is facilitated by the provision of a case summary illustrating the features required for comprehensive patient care. However, there are many cases in which the individual practicalities of applying such a case summary may not be straightforward. Common examples include finding the prescribed number of lymph nodes, trying to determine the levels of the radical neck dissection, and determining if isolated tumor cells in a lymph node represent metastatic disease. Case summaries have evolved to include clinical, radiographic, morphologic, immunohistochemical, and molecular results in an effort to guide clinical management. Adjuvant and neoadjuvant therapy can significantly alter histologic findings, making accurate classification an increasingly complex and demanding task. This protocol tries to remain simple while still incorporating important pathologic features as proposed by the American Joint Committee on Cancer (AJCC) cancer staging manual, the World Health Organization (WHO) classification of tumors, the TNM classification, the American College of Surgeons Commission on Cancer, and the International Union on Cancer (UICC). This protocol is to be used as a guide and resource, an adjunct to diagnosing and managing cancers of the pharynx in a standardized manner. It should not be used as a substitute for dissection or grossing techniques and does not give histologic parameters to reach the diagnosis. Subjectivity is always a factor, and elements listed are not meant to be arbitrary but are meant to provide uniformity of reporting across all the disciplines that use the information. It is a foundation of practical information that will help to meet the requirements of daily practice to benefit both clinicians and patients alike. A. Anatomical Sites and Subsites for PharynxThe pharynx is divided into 3 parts including the nasopharynx, oropharynx, and hypopharynx (Figure 1). Figure 1. Anatomic subdivisions and “contents” of the pharynx. From Hollinshead WH. Anatomy for Surgeons: The Head and Neck. 3rd ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 1982. Reproduced with permission ().Oropharynx (Figure 1)The oropharynx is the portion of the continuity of the pharynx extending from the plane of the superior surface of the soft palate to the superior surface of the hyoid bone or floor of the vallecula. ADDIN EN.CITE <EndNote><Cite><Author>Lydiatt</Author><Year>2017</Year><RecNum>4</RecNum><DisplayText><style face="superscript">2,3</style></DisplayText><record><rec-number>4</rec-number><foreign-keys><key app="EN" db-id="zwdte99espf0eae0wscvzr0zwa59wfd0v2zd" timestamp="1475711478">4</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author>Lydiatt, W.M.</author><author>Ridge, J.A.</author><author>Patel, S.G.</author><author>Brizel, D.M.</author><author>Haughey, B.H.</author><author>Glastonbury, C.M.</author><author>Brandwein-Gensler, M. S.</author><author>O'Sullivan, B.</author><author>Shah, J. P.</author></authors><secondary-authors><author>Amin, M.B.</author></secondary-authors></contributors><titles><title>Oropharynx (p16 -) and Hypopharynx</title><secondary-title>AJCC Cancer Staging Manual</secondary-title></titles><edition>8th</edition><dates><year>2017</year></dates><pub-location>New York, NY</pub-location><publisher>Springer</publisher><urls></urls></record></Cite><Cite><Author>O'Sullivan</Author><Year>2017</Year><RecNum>3</RecNum><record><rec-number>3</rec-number><foreign-keys><key app="EN" db-id="zwdte99espf0eae0wscvzr0zwa59wfd0v2zd" timestamp="1475711383">3</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author>O'Sullivan, B.</author><author>Lydiatt, W.M.</author><author>Haughey, B.H.</author><author>Brandwein-Gensler, M. S.</author><author>Glastonbury, C.M.</author><author>Shah, J. P.</author></authors><secondary-authors><author>Amin, M.B.</author></secondary-authors></contributors><titles><title>HPV Mediated (p16+) Oropharyngeal Cancer</title><secondary-title>AJCC Cancer Staging Manual</secondary-title></titles><edition>8th</edition><dates><year>2017</year></dates><pub-location>New York, NY</pub-location><publisher>Springer</publisher><urls></urls></record></Cite></EndNote>1,2 The contents of the oropharynx include: - soft palate- palatine tonsils- anterior and posterior tonsillar pillars- tonsillar fossa and tonsillar (faucial) pillars- uvula- base of tongue, including the lingual tonsils- vallecula- posterior oropharyngeal wallNasopharynx (Figure 1)The nasopharynx is situated behind the nasal cavity and above the soft palate; it begins anteriorly at the posterior choana and extends along the plane of the airway to the level of the free border of the soft palate.3 The contents of the nasopharynx include:- nasopharyngeal tonsils (adenoids) lie along the posterior and lateral of the nasopharynx- orifice of Eustachian tube lies along the lateral aspects of the nasopharyngeal wall- fossa of RosenmüllerHypopharynx (Figure 1)The hypopharynx is the portion of the pharynx extending from the plane of the superior border of the hyoid bone (or floor of the vallecula) to the plane corresponding to the lower border of the cricoid cartilage.1 The contents of the hypopharynx include:- piriform sinus (right and left) - represents part of the hypopharynx which expands bilaterally and forward around the sides of the larynx and lies between the larynx and the thyroid cartilage- lateral and posterior hypopharyngeal walls- postcricoid region extending from the level of the arytenoid cartilage and connecting folds to the inferior border of the cricoid cartilage; it connects the 2 piriform sinuses, thereby forming the anterior wall of the hypopharynxWaldeyer ring is formed by a ring or group of extranodal lymphoid tissues about the upper end of the pharynx (Figure 2) which consists of the:- palatine tonsils- pharyngeal tonsils (adenoids)- base of tongue/lingual tonsils- adjacent submucosal lymphaticsFigure 2. Waldeyer tonsillar tissues. From Hollinshead WH. Anatomy for Surgeons: The Head and Neck. 3rd ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 1982. Reproduced with permission ().References:Lydiatt WM, Ridge JA, Patel SG, et al. Oropharynx (p16 -) and hypopharynx. In: Amin MB, ed. AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017.O'Sullivan B, Lydiatt WM, Haughey BH, Brandwein-Gensler MS, Glastonbury CM, Shah JP. HPV mediated (p16+) oropharyngeal cancer. In: Amin MB, ed. AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017.Lee AWM, Lydiatt WM, Colevas AD, et al. Nasopharynx. In: Amin MB, ed. AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017.B. Histologic TypeA modification of the WHO classification of carcinomas of the oropharynx,1,2 the nasopharynx,3 and the hypopharynx4,5 is shown below. This list may not be complete. This protocol applies only to carcinomas and melanomas and does not apply to lymphomas or sarcomas.Carcinomas of the Oropharynx and Hypopharynx Squamous cell carcinomaHuman papillomavirus (HPV)-mediated (positive) squamous cell carcinoma (oropharynx only)#HPV-unrelated (negative) squamous cell carcinoma (oropharynx and hypopharynx)#Variants of Squamous Cell Carcinoma KeratinizingNonkeratinizingAcantholytic squamous cell carcinomaAdenosquamous carcinomaBasaloid squamous cell carcinomaPapillary squamous cell carcinomaSpindle cell squamous cell carcinomaVerrucous squamous cell carcinomaLymphoepithelial carcinoma # Modification based on separation of HPV-mediated (positive) and HPV-unrelated (negative) oropharyngeal squamous cell carcinoma in the AJCC 8th edition and WHO 4th edition.1,6,7 Carcinomas of the NasopharynxKeratinizing squamous cell carcinoma Nonkeratinizing squamous cell carcinomaBasaloid squamous cell carcinomaAdenocarcinomas Non-Salivary Gland TypeNasopharyngeal papillary adenocarcinoma, low-gradeCarcinomas of the Minor Salivary GlandsThe histologic classification recommended is a modification of the WHO classification of salivary gland tumors. Additional entities are covered in the major salivary gland protocol.Mucoepidermoid carcinomaAdenoid cystic carcinomaAcinic cell carcinomaPolymorphous adenocarcinoma (Mammary analogue) secretory carcinomaSalivary duct carcinomaCarcinoma ex pleomorphic adenomaEpithelial-myoepithelial carcinoma(Hyalinizing) clear cell carcinomaAdenocarcinoma, not otherwise specifiedBasal cell adenocarcinomaCarcinosarcomaIntraductal carcinomaLymphoepithelial carcinomaMyoepithelial carcinomaOncocytic carcinomaNeuroendocrine CarcinomaSmall cell neuroendocrine carcinoma, HPV negativeSmall cell neuroendocrine carcinoma, HPV positiveLarge cell neuroendocrine carcinoma, HPV negativeLarge cell neuroendocrine carcinoma, HPV positiveMucosal MelanomaReferences:1.El-Naggar AK, Takata T. Tumours of the oropharynx (base of tongue, tonsils, adenoids). In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, eds. WHO Classification of Head and Neck Tumours. Geneva, Switzerland: WHO Press; 2017:134-136.2.Slootweg P, Eveson JW. Tumours of the oral cavity and oropharynx. In: Barnes L, Eveson JW, Reichart P, Sidransky D, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Head and Neck Tumours. Lyon, France: IARC; 2005:164-167.3.Chan JKC, Slootweg P. Introduction. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, eds. WHO Classification of Head and Neck Tumours. Geneva, Switzerland: WHO Press; 2017:64-65.4.Slootweg PJ, Grandis JR. Tumours of the hypopharynx, larynx and trachea and parapharyngeal space. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, eds. WHO Classification of Head and Neck Tumours. Geneva, Switzerland: WHO Press; 2017:78-81.5.Barnes L, Slootweg P, Tse LL, et al. Tumours of the hypopharynx, larynx and trachea. In: Barnes L, Eveson JW, Reichart P, Sidransky D, eds. World Health Organization Classification of Tumours:Lydiatt WM, Ridge JA, Patel SG, et al. Oropharynx (p16 -) and hypopharynx. In: Amin MB, ed. AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017.O'Sullivan B, Lydiatt WM, Haughey BH, Brandwein-Gensler MS, Glastonbury CM, Shah JP. HPV mediated (p16+) oropharyngeal cancer. In: Amin MB, ed. AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017.C. Histologic GradeFor histologic types of carcinomas that are amenable to grading, 3 histologic grades are suggested, as shown below. For conventional squamous cell carcinoma, histologic grading as a whole does not perform well as a prognosticator. ADDIN EN.CITE <EndNote><Cite><Author>Barnes</Author><Year>2005</Year><RecNum>8</RecNum><DisplayText><style face="superscript">10</style></DisplayText><record><rec-number>8</rec-number><foreign-keys><key app="EN" db-id="zwdte99espf0eae0wscvzr0zwa59wfd0v2zd" timestamp="1475714994">8</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author>Barnes, L.</author><author>Eveson, J.W.</author><author>Reichart, P.</author><author>Sidransky, D.</author></authors><secondary-authors><author>Barnes, L.</author><author>Eveson, J.W.</author><author>Reichart, P.</author><author>Sidransky, D.</author></secondary-authors></contributors><titles><title>WHO histological classification of tumours of the oral cavity and oropharynx</title><secondary-title>World Health Organization classification of tumours: Pathology and genetics of head and neck tumours</secondary-title></titles><pages>164</pages><dates><year>2005</year></dates><pub-location>Lyon</pub-location><publisher>IARC</publisher><urls></urls></record></Cite></EndNote>1 Nonetheless, it should be recorded when applicable, as it is a basic tumor characteristic. Specifically, it is only applicable for HPV-unrelated/negative oropharyngeal carcinomas and hypopharyngeal carcinomas. HPV-mediated/positive squamous cell carcinoma is not graded, and nasopharyngeal carcinoma is typed as above but does not otherwise require grading.2,PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5DaGFuPC9BdXRob3I+PFllYXI+MjAxNzwvWWVhcj48UmVj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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5DaGFuPC9BdXRob3I+PFllYXI+MjAxNzwvWWVhcj48UmVj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ADDIN EN.CITE.DATA 3,4 Selecting either the most prevalent grade or the highest grade for this synoptic protocol is acceptable. Variants of squamous cell carcinoma (ie, verrucous, basaloid, etc) have an intrinsic biologic potential and currently do not appear to require grading.Grade 1Well differentiatedGrade 2Moderately differentiatedGrade 3Poorly differentiatedGrade XCannot be assessedThe histologic (microscopic) grading of salivary gland carcinomas has been shown to be an independent predictor of behavior and plays a role in optimizing therapy. Further, there is often a positive correlation between histologic grade and clinical stage.5-8 However, most salivary gland carcinoma types have an intrinsic biologic behavior, and attempted application of a universal grading scheme is merely a crude surrogate.7 Thus, a generic grading scheme is no longer recommended for salivary gland carcinomas.3 Carcinoma types for which grading systems exist and are relevant are incorporated into histologic type. The 3 major categories that are amenable to grading include adenoid cystic carcinoma, mucoepidermoid carcinoma, and adenocarcinoma, not otherwise specified.6,7,9 In some carcinomas, histologic grading may be based on growth pattern, such as in adenoid cystic carcinoma, for which a histologic high-grade variant has been recognized based on the percentage of solid growth.9 Those adenoid cystic carcinomas showing 30% or greater of solid growth pattern are considered to be histologically high-grade carcinomas. The histologic grading of mucoepidermoid carcinoma includes a combination of growth pattern characteristics (eg, cystic, solid, neurotropism) and cytomorphologic findings (eg, anaplasia, mitoses, necrosis).PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TZWV0aGFsYTwvQXV0aG9yPjxZZWFyPjIwMTA8L1llYXI+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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TZWV0aGFsYTwvQXV0aG9yPjxZZWFyPjIwMTA8L1llYXI+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ADDIN EN.CITE.DATA 10-12 Adenocarcinomas, not otherwise specified, do not have a formalized grading scheme and are graded intuitively based on cytomorphologic features. ADDIN EN.CITE <EndNote><Cite><Author>Seethala</Author><Year>2011</Year><RecNum>11</RecNum><DisplayText><style face="superscript">13</style></DisplayText><record><rec-number>11</rec-number><foreign-keys><key app="EN" db-id="zwdte99espf0eae0wscvzr0zwa59wfd0v2zd" timestamp="1475714994">11</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Seethala, R. R.</author></authors></contributors><auth-address>Department of Pathology and Laboratory Medicine, University of Pittsburgh Medical Center, 200 Lothrop Street, Pittsburgh, PA 15213, USA. seethalarr@upmc.edu</auth-address><titles><title>Histologic grading and prognostic biomarkers in salivary gland carcinomas</title><secondary-title>Adv Anat Pathol</secondary-title></titles><periodical><full-title>Adv Anat Pathol</full-title></periodical><pages>29-45</pages><volume>18</volume><number>1</number><keywords><keyword>Adenoma, Pleomorphic/pathology</keyword><keyword>Biomarkers, Tumor/*analysis</keyword><keyword>Carcinoma, Acinar Cell/pathology</keyword><keyword>Carcinoma, Adenoid Cystic/pathology</keyword><keyword>Carcinoma, Mucoepidermoid/pathology</keyword><keyword>Humans</keyword><keyword>Ki-67 Antigen/analysis</keyword><keyword>Oncogene Proteins, Fusion/analysis</keyword><keyword>Prognosis</keyword><keyword>Salivary Gland Neoplasms/*pathology</keyword><keyword>Salivary Glands/*pathology</keyword></keywords><dates><year>2011</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1533-4031 (Electronic)
1072-4109 (Linking)</isbn><accession-num>21169736</accession-num><urls><related-urls><url> Polymorphous adenocarcinomas are to be graded as per current WHO recommendations, though these are also graded intuitively as there are no listed criteria.Carcinoma ex pleomorphic adenoma is subclassifed by histologic type and or grade and extent of invasion, the latter including minimally invasive, widely invasive, and intracapsular (noninvasive) cancers. Previously the cut-off for minimal invasion was designated as 1.5 mm; however, more recent studies have shown a favorable prognosis even with cut-offs of 4 mm to 6 mm. ADDIN EN.CITE <EndNote><Cite><Author>Williams</Author><Year>2017</Year><RecNum>132</RecNum><DisplayText><style face="superscript">19</style></DisplayText><record><rec-number>132</rec-number><foreign-keys><key app="EN" db-id="9p9svxxdw99pdvepr5zvs52r95w29ewx22wp" timestamp="1494551678">132</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author>Williams, M.D.</author><author>Ihrler, S.</author><author>Seethala, R. R.</author></authors><secondary-authors><author>El-Naggar, A.K.</author><author>Chan, J. K. C.</author><author>Grandis, J.R.</author><author>Takata, T.</author><author>Slootweg, P.J.</author></secondary-authors></contributors><titles><title>Carcinoma ex pleomorphic adenoma</title><secondary-title>World Health Organization classification of tumours: Pathology and genetics of head and neck tumours</secondary-title></titles><pages>176-177</pages><edition>4th</edition><dates><year>2017</year></dates><pub-location>Lyon</pub-location><publisher>IARC</publisher><urls></urls></record></Cite></EndNote>13 Thus, there is no agreement on an optimal cut-off. However, from a practical standpoint, the terms intracapsular, and minimally invasive should only be applied to uninodular tumors (as opposed to carcinomas arising in multinodular recurrent pleomorphic adenomas) with a well-delineated interface for which the entire lesional border has been microscopically evaluated. Prognosis has been linked to degree of invasion with noninvasive and minimally invasive cancers apparently having a better prognosis than invasive cancers.7,PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TZWV0aGFsYTwvQXV0aG9yPjxZZWFyPjIwMTE8L1llYXI+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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TZWV0aGFsYTwvQXV0aG9yPjxZZWFyPjIwMTE8L1llYXI+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ADDIN EN.CITE.DATA 13,14 References1.Barnes L, Eveson JW, Reichart P, Sidransky D. WHO histological classification of tumours of the oral cavity and oropharynx. In: Barnes L, Eveson JW, Reichart P, Sidransky D, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Head and Neck Tumours. Lyon, France: IARC; 2005:164.2.O'Sullivan B, Lydiatt WM, Haughey BH, Brandwein-Gensler MS, Glastonbury CM, Shah JP. HPV mediated (p16+) oropharyngeal cancer. In: Amin MB, ed. AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017.3.Lee AWM, Lydiatt WM, Colevas AD, et al. Nasopharynx. In: Amin MB, ed. AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017.4.Chan JKC, Slootweg P. Introduction. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, eds. WHO Classification of Head and Neck Tumours. Geneva, Switzerland: WHO Press; 2017:64-65.5.Spiro RH, Thaler HT, Hicks WF, Kher UA, Huvos AH, Strong EW. The importance of clinical staging of minor salivary gland carcinoma. Am J Surg. 1991;162(4):330-336.6.Spiro RH, Huvos AG, Strong EW. Adenocarcinoma of salivary origin: clinicopathologic study of 204 patients. Am J Surg. 1982;144(4):423-431.7.Seethala RR. Histologic grading and prognostic biomarkers in salivary gland carcinomas. Adv Anat Pathol. 2011;18(1):29-45.8.Kane WJ, McCaffrey TV, Olsen KD, Lewis JE. Primary parotid malignancies: a clinical and pathologic review. Arch Otolaryngol Head Neck Surg. 1991;117(3):307-315.9.Szanto PA, Luna MA, Tortoledo ME, White RA. Histologic grading of adenoid cystic carcinoma of the salivary glands. Cancer. 1984;54(6):1062-1069.10.Seethala RR, Dacic S, Cieply K, Kelly LM, Nikiforova MN. A reappraisal of the MECT1/MAML2 translocation in salivary mucoepidermoid carcinomas. Am J Surg Pathol. 2010;34(8):1106-1121.11.Brandwein MS, Ivanov K, Wallace DI, et al. Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading. Am J Surg Pathol. 2001;25(7):835-845.12.Auclair PL, Goode RK, Ellis GL. Mucoepidermoid carcinoma of intraoral salivary glands: evaluation and application of grading criteria in 143 cases. Cancer. 1992;69(8):2021-2030.13.Williams MD, Ihrler S, Seethala RR. Carcinoma ex pleomorphic adenoma. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, eds. WHO Classification of Head and Neck Tumours. Geneva, Switzerland: WHO Press; 2017:176-177.14.Brandwein M, Huvos AG, Dardick I, Thomas MJ, Theise ND. Noninvasive and minimally invasive carcinoma ex mixed tumor: a clinicopathologic and ploidy study of 12 patients with major salivary tumors of low (or no?) malignant potential. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;81(6):655-664.D. Surgical MarginsHistorically, documentation of margin status for many oropharyngeal and hypopharyngeal tumors was not possible, and they were not oncologically resected but rather treated with chemotherapy and radiation. With the advent of transoral robotic and laser surgery, however, intact resections have become increasingly common. Limited evidence suggests that at the very minimum, a positive margin is represented by invasive carcinoma present at margin (microscopic cut-through of tumor).PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5XZWluc3RlaW48L0F1dGhvcj48WWVhcj4yMDA3PC9ZZWFy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==
ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5XZWluc3RlaW48L0F1dGhvcj48WWVhcj4yMDA3PC9ZZWFy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==
ADDIN EN.CITE.DATA 1-3 Akin to other sites, there is no standard definition of a “close” margin, and definitions have ranged from 2 mm to 5 mm.PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5SdWJlazwvQXV0aG9yPjxZZWFyPjIwMTc8L1llYXI+PFJl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 EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5SdWJlazwvQXV0aG9yPjxZZWFyPjIwMTc8L1llYXI+PFJl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 EN.CITE.DATA 2 Despite the paucity of data, in keeping with other sites, the distance from the nearest margin should be recorded.For hypopharyngeal and HPV-negative oropharyngeal tumors, in situ disease and high-grade dysplasia is plausible, and if present at a margin, the margin is considered positive in line with other sites. When such lesions are identified in pharyngeal sites, it usually occurs in association with an invasive carcinoma. In this setting, the same criteria detailed in the oral cavity and laryngeal protocols apply (see Protocol for the Examination of Specimens from Patients with Carcinomas of the Lip and Oral Cavity and Protocol for the Examination of Specimens from Patients with Carcinomas of the Larynx).For HPV-positive oropharyngeal carcinoma, in situ disease for practical purposes nonexistent, likely given their derivation from the specialized “lymphoepithelium” of tonsillar crypt.PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5NYXJ1cjwvQXV0aG9yPjxZZWFyPjIwMTA8L1llYXI+PFJl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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5NYXJ1cjwvQXV0aG9yPjxZZWFyPjIwMTA8L1llYXI+PFJl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ADDIN EN.CITE.DATA 4Nasopharyngeal tumors are still generally not resected and margin status is usually not able to be documented.References:1.Weinstein GS, O'Malley BW, Jr., Snyder W, Sherman E, Quon H. Transoral robotic surgery: radical tonsillectomy. Arch Otolaryngol Head Neck Surg. 2007;133(12):1220-1226.2.Rubek N, Channir HI, Charabi BW, et al. Primary transoral robotic surgery with concurrent neck dissection for early stage oropharyngeal squamous cell carcinoma implemented at a Danish head and neck cancer center: a phase II trial on feasibility and tumour margin status. Eur Arch Otorhinolaryngol. 2017;274(5):2229-2237.3.Weiss BG, Ihler F, Wolff HA, et al. Transoral laser microsurgery for treatment for hypopharyngeal cancer in 211 patients. Head Neck. 2017.4.Marur S, D'Souza G, Westra WH, Forastiere AA. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010;11(8):781-789.E. Orientation of SpecimenComplex specimens should be examined and oriented with the assistance of the operating surgeon(s). Direct communication between the surgeon and pathologist is a critical component in specimen orientation and proper sectioning. Whenever possible, the tissue examination request form should include a drawing or photograph of the resected specimen showing the extent of the tumor and its relation to the anatomic structures of the region. The lines and extent of the resection can be depicted on preprinted adhesive labels and attached to the surgical pathology request forms.F. Perineural InvasionTraditionally, the presence of perineural invasion (neurotropism) is an important predictor of poor prognosis in head and neck cancer of virtually all sites.1 The presence of perineural invasion (neurotropism) in the primary cancer is associated with poor local disease control and regional control, as well as being associated with metastasis to regional lymph nodes.1 Further, perineural invasion is associated with decrease in disease-specific survival and overall survival.1 There is conflicting data relative to an association between the presence of perineural invasion and the development of distant metastasis, with some studies showing an increased association with distant metastasis, while other studies showing no correlation with distant metastasis.1 The relationship between perineural invasion and prognosis is independent of nerve diameter.2 Additionally, emerging evidence suggests that extratumoral perineural invasion may be more prognostically relevant.3 Although perineural invasion of small unnamed nerves may not produce clinical symptoms, the reporting of perineural invasion includes nerves of all sizes including small peripheral nerves (ie, less than 1 mm in diameter). Aside from the impact on prognosis, the presence of perineural invasion also guides therapy. Concurrent adjuvant chemoradiation therapy has been shown to improve outcomes in patients with perineural invasion (as well as in patients with extranodal extension and bone invasion).4,5 While oropharyngeal, hypopharyngeal, and nasopharyngeal site specific data are limited, given the significance relative to prognosis and treatment for head and neck cancers in general, perineural invasion is a required data element in the reporting at these sites as well.References:1.Smith BD, Haffty BG. Prognostic factoris in patients with head and neck cancer. In: Harrison LB, Sessions RB, Hong WK, eds. Head and Neck Cancer: A Multidisciplinary Approach. Philadelphia, PA: Lippincott Williams and Wilkins; 2009:51-75.2.Fagan JJ, Collins B, Barnes L, D'Amico F, Myers EN, Johnson JT. Perineural invasion in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 1998;124(6):637-640.3.Miller ME, Palla B, Chen Q, et al. A novel classification system for perineural invasion in noncutaneous head and neck squamous cell carcinoma: histologic subcategories and patient outcomes. Am J Otolaryngol. 2012;33(2):212-215.4.Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004;350(19):1937-1944.5.Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350(19):1945-1952.G. Lymph Nodes Measurement of Tumor MetastasisThe cross-sectional diameter of the largest lymph node metastasis (not the lymph node itself) is measured in the gross specimen at the time of macroscopic examination or, if necessary, on the histologic slide at the time of microscopic examination. 1,2Special Procedures for Lymph NodesThe risk of regional (cervical neck) nodal spread from cancers of the pharynx is high. The majority of metastatic carcinomas to the cervical lymph nodes take origin from a head and neck primary carcinoma. The most common histologic type of carcinoma to metastasize to cervical neck lymph nodes is squamous cell carcinoma. Cervical nodal metastases may occur in the setting of an unknown primary carcinoma referred to as metastatic cervical carcinoma with an unknown primary (CUP). As per AJCC 8th edition guidelines,3 3 separate approaches are employed to stage patients who present with an occult primary tumor. The primary T category is described as T0 and the N category is designated according to the respective anatomic site based on Epstein-Barr virus (EBV) and HPV status: Patients with EBV-related cervical adenopathy are staged according to N staging in nasopharynx.Patients with HPV-mediated (positive) cervical adenopathy are staged according to N staging in HPV-mediated/ p16 positive oropharyngeal cancer. All other patients with EBV-unrelated and HPV-unrelated cervical adenopathy are staged according to the generic N stage category used for the other head and neck sites, and for unknown primary. This takes into account the site-specific differences in prognostic impact for metastatic nodal disease. Both HPV- and EBV-driven nodal metastases are typically nonkeratinizing, with the former often being cystic. When encountering this morphology, HPV and EBV testing as suggested in the CAP Head and Neck Biomarker template is critical.Aside from these, no additional special techniques are required other than routine histology for the assessment of nodal metastases. Immunohistochemistry and polymerase chain reaction (PCR) to detect isolated tumor cells are considered investigational techniques at this time.Regional Lymph Nodes (pN0): Isolated Tumor CellsIsolated tumor cells (ITCs) are single cells or small clusters of cells not more than 0.2 mm in greatest dimension. While the generic recommendation is that for lymph nodes with ITCs found by either histologic examination, immunohistochemistry, or nonmorphologic techniques (eg, flow cytometry, DNA analysis, PCR amplification of a specific tumor marker), they should be classified as N0 or M0, respectively.4,5 Evidence for the validity of this practice in head and neck squamous cell carcinoma and other histologic subtypes is lacking. In fact, rare studies relevant to head and neck sites indicate that isolated tumor cells may actually be a poor prognosticator in terms of local control.6Lymph Node NumberFor assessment of pN, a selective neck dissection will ordinarily include 10 or more lymph nodes, and a comprehensive neck dissection (radical or modified radical neck dissection) will ordinarily include 15 or more lymph nodes. Examination of fewer tumor-free nodes still mandates a pN0 designation.Classification of Neck Dissection1.Radical neck dissection2.Modified radical neck dissection, internal jugular vein and/or sternocleidomastoid muscle spared3.Selective neck dissection (SND), as specified by the surgeon (Figure 3), defined by dissection of less than the 5 traditional levels of a radical and modified radical neck dissection. The following dissections are now under this categoryPEVuZE5vdGU+PENpdGU+PEF1dGhvcj5GZXJsaXRvPC9BdXRob3I+PFllYXI+MjAxMTwvWWVhcj48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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5GZXJsaXRvPC9BdXRob3I+PFllYXI+MjAxMTwvWWVhcj48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ADDIN EN.CITE.DATA 7-9:a.Supraomohyoid neck dissectionb.Posterolateral neck dissectionc.Lateral neck dissectiond.Central compartment neck dissection4.Superselective neck dissection (SSND), a relatively new term defined by dissection of the fibrofatty elements of 2 or less levels. ADDIN EN.CITE <EndNote><Cite><Author>Suarez</Author><Year>2013</Year><RecNum>41</RecNum><DisplayText><style face="superscript">57</style></DisplayText><record><rec-number>41</rec-number><foreign-keys><key app="EN" db-id="tzavz5dscvxrvue0dwa59s9ywdetsdpradet" timestamp="1475550065">41</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Suarez, C.</author><author>Rodrigo, J. P.</author><author>Robbins, K. T.</author><author>Paleri, V.</author><author>Silver, C. E.</author><author>Rinaldo, A.</author><author>Medina, J. E.</author><author>Hamoir, M.</author><author>Sanabria, A.</author><author>Mondin, V.</author><author>Takes, R. P.</author><author>Ferlito, A.</author></authors></contributors><auth-address>Department of Otolaryngology, Hospital Universitario Central de Asturias, Oviedo, Spain.</auth-address><titles><title>Superselective neck dissection: rationale, indications, and results</title><secondary-title>Eur Arch Otorhinolaryngol</secondary-title></titles><periodical><full-title>Eur Arch Otorhinolaryngol</full-title></periodical><edition>2013/01/17</edition><dates><year>2013</year><pub-dates><date>Jan 16</date></pub-dates></dates><isbn>1434-4726 (Electronic)
0937-4477 (Linking)</isbn><accession-num>23321797</accession-num><urls><related-urls><url>. Extended radical neck dissection, as specified by the surgeonFor purposes of pathologic evaluation, lymph nodes are organized by levels as shown in Figure 4. Figure 4. The six sublevels of the neck for describing the location of lymph nodes within levels I, II, and V. Level IA, submental group; level IB, submandibular group; level IIA, upper jugular nodes along the carotid sheath, including the subdigastric group; level IIB, upper jugular nodes in the submuscular recess; level VA, spinal accessory nodes; and level VB, the supraclavicular and transverse cervical nodes. From Flint PW et al, eds. Cummings Otolaryngology: Head and Neck Surgery. 5th ed. Philadelphia, PA; Saunders: 2010. Reproduced with permission ??Elsevier.In order for pathologists to properly identify these nodes, they must be familiar with the terminology of the regional lymph node groups and with the relationships of those groups to the regional anatomy. Which lymph node groups surgeons submit for histopathologic evaluation depends on the type of neck dissection they perform. Therefore, surgeons must supply information on the types of neck dissections that they perform and on the details of the local anatomy in the specimens they submit for examination or, in other manners, orient those specimens for pathologists.If it is not possible to assess the levels of lymph nodes (for instance, when the anatomic landmarks in the excised specimens are not specified), then the lymph node levels may be estimated as follows: level II, upper third of internal jugular (IJ) vein or neck specimen; level III, middle third of IJ vein or neck specimen; level IV, lower third of IJ vein or neck specimen, all anterior to the sternocleidomastoid muscle.Level I. Submental Group (Sublevel IA) Lymph nodes within the triangular boundary of the anterior belly of the digastric muscles and the hyoid bone.Level I. Submandibular Group (Sublevel IB)Lymph nodes within the boundaries of the anterior and posterior bellies of the digastric muscle and the body of the mandible. The submandibular gland is included in the specimen when the lymph nodes within this triangle are removed.Level II. Upper Jugular Group (Sublevels IIA and IIB)Lymph nodes located around the upper third of the internal jugular vein and adjacent spinal accessory nerve extending from the level of the carotid bifurcation (surgical landmark) or hyoid bone (clinical landmark) to the skull base. The posterior boundary is the posterior border of the sternocleidomastoid muscle, and the anterior boundary is the lateral border of the stylohyoid muscle.Level III. Middle Jugular Group Lymph nodes located around the middle third of the internal jugular vein extending from the carotid bifurcation superiorly to the omohyoid muscle (surgical landmark), or cricothyroid notch (clinical landmark) inferiorly. The posterior boundary is the posterior border of the sternocleidomastoid muscle, and the anterior boundary is the lateral border of the sternohyoid muscle.Level IV. Lower Jugular Group Lymph nodes located around the lower third of the internal jugular vein extending from the omohyoid muscle superiorly to the clavicle inferiorly. The posterior boundary is the posterior border of the sternocleidomastoid muscle, and the anterior boundary is the lateral border of the sternohyoid muscle.Level V. Posterior Triangle Group (Sublevels VA and VB)This group comprises predominantly the lymph nodes located along the lower half of the spinal accessory nerve and the transverse cervical artery. The supraclavicular nodes are also included in this group. The posterior boundary of the posterior triangle is the anterior border of the trapezius muscle, the anterior boundary of the posterior triangle is the posterior border of the sternocleidomastoid muscle, and the inferior boundary of the posterior triangle is the clavicle.Level VI. Anterior (Central) CompartmentLymph nodes in this compartment include the pre- and paratracheal nodes, precricoid (Delphian) node, and the perithyroidal nodes, including the lymph nodes along the recurrent laryngeal nerve. The superior boundary is the hyoid bone, the inferior boundary is the suprasternal notch, the lateral boundaries are the common carotid arteries, and the posterior boundary by the prevertebral fascia. Level VII. Superior Mediastinal Lymph NodesMetastases at level VII are considered regional lymph node metastases; all other mediastinal lymph node metastases are considered distant metastases. Lymph node groups removed from areas not included in the above levels, eg, scalene, suboccipital, and retropharyngeal, should be identified and reported from all levels separately. When staging lymph node involvement by metastases from nasopharyngeal carcinoma, the supraclavicular fossa refers to a triangular region, the base of which is the superior margin of the clavicle between its sternal and lateral ends, and the apex of which is the point where the neck meets the shoulder. This includes caudal portions of Levels IV and V (see above). All cancers metastatic to the posterior nodes in the supraclavicular fossa are designated as N3b. Midline nodes are considered ipsilateral nodes.Extranodal Extension The status of cervical lymph nodes is the single most important prognostic factor in aerodigestive cancer. All macroscopically negative or equivocal lymph nodes should be submitted in toto. Grossly positive nodes may be partially submitted for microscopic documentation of metastasis. For HPV-unrelated/p16-negative oropharyngeal cancers and hypopharyngeal cancers, reporting of lymph nodes containing metastasis should include whether there is presence or absence of extranodal extension (ENE),11 which is now part of N staging for these tumor types. This finding consists of extension of metastatic tumor, present within the confines of the lymph node, through the lymph node capsule into the surrounding connective tissue, with or without associated stromal reaction. A distance of extension from the native lymph node capsule is now suggested (but not yet required) with the proposed stratification of ENE into ENEma (greater than 2 mm) and ENEmi (less than or equal to 2 mm).PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5SaWRnZTwvQXV0aG9yPjxZZWFyPjIwMTc8L1llYXI+PFJl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 EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5SaWRnZTwvQXV0aG9yPjxZZWFyPjIwMTc8L1llYXI+PFJl
Y051bT4zNjwvUmVjTnVtPjxEaXNwbGF5VGV4dD48c3R5bGUgZmFjZT0ic3VwZXJzY3JpcHQiPjQz
LTQ2PC9zdHlsZT48L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+MzY8L3JlYy1udW1i
ZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJ6d2R0ZTk5ZXNwZjBlYWUwd3Nj
dnpyMHp3YTU5d2ZkMHYyemQiIHRpbWVzdGFtcD0iMTQ3NTcxNDk5NyI+MzY8L2tleT48L2ZvcmVp
Z24ta2V5cz48cmVmLXR5cGUgbmFtZT0iQm9vayBTZWN0aW9uIj41PC9yZWYtdHlwZT48Y29udHJp
YnV0b3JzPjxhdXRob3JzPjxhdXRob3I+UmlkZ2UsIEouQS48L2F1dGhvcj48YXV0aG9yPkx5ZGlh
dHQsIFcuTS48L2F1dGhvcj48YXV0aG9yPlBhdGVsLCBTLkcuPC9hdXRob3I+PGF1dGhvcj5HbGFz
dG9uYnVyeSwgQy5NLjwvYXV0aG9yPjxhdXRob3I+QnJhbmR3ZWluLUdlbnNsZXIsIE0uIFMuPC9h
dXRob3I+PGF1dGhvcj5HaG9zc2VpbiwgUi5BLjwvYXV0aG9yPjxhdXRob3I+U2hhaCwgSi4gUC48
L2F1dGhvcj48L2F1dGhvcnM+PHNlY29uZGFyeS1hdXRob3JzPjxhdXRob3I+QW1pbiwgTS5CLjwv
YXV0aG9yPjwvc2Vjb25kYXJ5LWF1dGhvcnM+PC9jb250cmlidXRvcnM+PHRpdGxlcz48dGl0bGU+
TGlwIGFuZCBvcmFsIGNhdml0eTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5BSkNDIENhbmNlciBT
dGFnaW5nIE1hbnVhbDwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxlZGl0aW9uPjh0aDwvZWRp
dGlvbj48ZGF0ZXM+PHllYXI+MjAxNzwveWVhcj48L2RhdGVzPjxwdWItbG9jYXRpb24+TmV3IFlv
cmssIE5ZPC9wdWItbG9jYXRpb24+PHB1Ymxpc2hlcj5TcHJpbmdlcjwvcHVibGlzaGVyPjx1cmxz
PjwvdXJscz48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5FYnJhaGltaTwvQXV0aG9yPjxZ
ZWFyPjIwMTQ8L1llYXI+PFJlY051bT4zNzwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+Mzc8
L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJ6d2R0ZTk5ZXNw
ZjBlYWUwd3NjdnpyMHp3YTU5d2ZkMHYyemQiIHRpbWVzdGFtcD0iMTQ3NTcxNDk5NyI+Mzc8L2tl
eT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVm
LXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkVicmFoaW1pLCBBLjwvYXV0aG9y
PjxhdXRob3I+Q2xhcmssIEouIFIuPC9hdXRob3I+PGF1dGhvcj5BbWl0LCBNLjwvYXV0aG9yPjxh
dXRob3I+WWVuLCBULiBDLjwvYXV0aG9yPjxhdXRob3I+TGlhbywgQy4gVC48L2F1dGhvcj48YXV0
aG9yPktvd2Fsc2tpLCBMLiBQLjwvYXV0aG9yPjxhdXRob3I+S3JlcHBlbCwgTS48L2F1dGhvcj48
YXV0aG9yPkNlcm5lYSwgQy4gUi48L2F1dGhvcj48YXV0aG9yPkJhY2hhciwgRy48L2F1dGhvcj48
YXV0aG9yPlZpbGxhcmV0LCBBLiBCLjwvYXV0aG9yPjxhdXRob3I+Rmxpc3MsIEQuPC9hdXRob3I+
PGF1dGhvcj5GcmlkbWFuLCBFLjwvYXV0aG9yPjxhdXRob3I+Um9iYmlucywgSy4gVC48L2F1dGhv
cj48YXV0aG9yPlNoYWgsIEouIFAuPC9hdXRob3I+PGF1dGhvcj5QYXRlbCwgUy4gRy48L2F1dGhv
cj48YXV0aG9yPkdpbCwgWi48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgt
YWRkcmVzcz5TeWRuZXkgSGVhZCBhbmQgTmVjayBDYW5jZXIgSW5zdGl0dXRlLCBSb3lhbCBQcmlu
Y2UgQWxmcmVkIEhvc3BpdGFsLCBTeWRuZXksIE5TVywgQXVzdHJhbGlhLCBlYnJhaGltaS5hcmRh
bGFuQHBvc3QuaGFydmFyZC5lZHUuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+TWluaW11
bSBub2RhbCB5aWVsZCBpbiBvcmFsIHNxdWFtb3VzIGNlbGwgY2FyY2lub21hOiBkZWZpbmluZyB0
aGUgc3RhbmRhcmQgb2YgY2FyZSBpbiBhIG11bHRpY2VudGVyIGludGVybmF0aW9uYWwgcG9vbGVk
IHZhbGlkYXRpb24gc3R1ZHk8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+QW5uIFN1cmcgT25jb2w8
L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPkFubmFscyBvZiBzdXJnaWNhbCBvbmNvbG9neTwv
YWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkFubmFscyBvZiBzdXJn
aWNhbCBvbmNvbG9neTwvZnVsbC10aXRsZT48YWJici0xPkFubiBTdXJnIE9uY29sPC9hYmJyLTE+
PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5Bbm5hbHMgb2Ygc3VyZ2lj
YWwgb25jb2xvZ3k8L2Z1bGwtdGl0bGU+PGFiYnItMT5Bbm4gU3VyZyBPbmNvbDwvYWJici0xPjwv
YWx0LXBlcmlvZGljYWw+PHBhZ2VzPjMwNDktNTU8L3BhZ2VzPjx2b2x1bWU+MjE8L3ZvbHVtZT48
bnVtYmVyPjk8L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29y
ZD5DYXJjaW5vbWEsIFNxdWFtb3VzIENlbGwvbW9ydGFsaXR5L3NlY29uZGFyeS8qc3VyZ2VyeTwv
a2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+Rm9sbG93LVVwIFN0dWRp
ZXM8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPkludGVybmF0aW9u
YWwgQWdlbmNpZXM8L2tleXdvcmQ+PGtleXdvcmQ+THltcGggTm9kZSBFeGNpc2lvbi8qc3RhbmRh
cmRzPC9rZXl3b3JkPjxrZXl3b3JkPkx5bXBoYXRpYyBNZXRhc3Rhc2lzPC9rZXl3b3JkPjxrZXl3
b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+
TW91dGggTmVvcGxhc21zL21vcnRhbGl0eS9wYXRob2xvZ3kvKnN1cmdlcnk8L2tleXdvcmQ+PGtl
eXdvcmQ+TmVvcGxhc20gUmVjdXJyZW5jZSwgTG9jYWwvbW9ydGFsaXR5L3BhdGhvbG9neS8qc3Vy
Z2VyeTwva2V5d29yZD48a2V5d29yZD5OZW9wbGFzbSBTdGFnaW5nPC9rZXl3b3JkPjxrZXl3b3Jk
PlByb2dub3Npczwva2V5d29yZD48a2V5d29yZD4qU3RhbmRhcmQgb2YgQ2FyZTwva2V5d29yZD48
a2V5d29yZD5TdXJ2aXZhbCBSYXRlPC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIw
MTQ8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5TZXA8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48
aXNibj4xNTM0LTQ2ODEgKEVsZWN0cm9uaWMpJiN4RDsxMDY4LTkyNjUgKExpbmtpbmcpPC9pc2Ju
PjxhY2Nlc3Npb24tbnVtPjI0NzI4ODIzPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVy
bHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzI0NzI4ODIzPC91cmw+
PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMjQ1L3Mx
MDQzNC0wMTQtMzcwMi14PC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+
PENpdGU+PEF1dGhvcj5QcmFiaHU8L0F1dGhvcj48WWVhcj4yMDE0PC9ZZWFyPjxSZWNOdW0+Mzg8
L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjM4PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+
PGtleSBhcHA9IkVOIiBkYi1pZD0iendkdGU5OWVzcGYwZWFlMHdzY3Z6cjB6d2E1OXdmZDB2Mnpk
IiB0aW1lc3RhbXA9IjE0NzU3MTQ5OTciPjM4PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBl
IG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhv
cnM+PGF1dGhvcj5QcmFiaHUsIFIuIFMuPC9hdXRob3I+PGF1dGhvcj5IYW5hc29nZSwgUy48L2F1
dGhvcj48YXV0aG9yPk1hZ2xpb2NjYSwgSy4gUi48L2F1dGhvcj48YXV0aG9yPk1vZWxsZXIsIEIu
IEouPC9hdXRob3I+PGF1dGhvcj5NaWxhcywgWi4gTC48L2F1dGhvcj48YXV0aG9yPkhhbGwsIFcu
IEEuPC9hdXRob3I+PGF1dGhvcj5FbC1EZWlyeSwgTS48L2F1dGhvcj48YXV0aG9yPldhZHN3b3J0
aCwgSi4gVC48L2F1dGhvcj48YXV0aG9yPkhpZ2dpbnMsIEsuIEEuPC9hdXRob3I+PGF1dGhvcj5C
ZWl0bGVyLCBKLiBKLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRy
ZXNzPlNvdXRoZWFzdCBSYWRpYXRpb24gT25jb2xvZ3kgR3JvdXAsIExldmluZSBDYW5jZXIgSW5z
dGl0dXRlLCBDaGFybG90dGUsIE5vcnRoIENhcm9saW5hLjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+
PHRpdGxlPkV4dGVudCBvZiBwYXRob2xvZ2ljIGV4dHJhY2Fwc3VsYXIgZXh0ZW5zaW9uIGFuZCBv
dXRjb21lcyBpbiBwYXRpZW50cyB3aXRoIG5vbm9yb3BoYXJ5bmdlYWwgaGVhZCBhbmQgbmVjayBj
YW5jZXIgdHJlYXRlZCB3aXRoIGluaXRpYWwgc3VyZ2ljYWwgcmVzZWN0aW9uPC90aXRsZT48c2Vj
b25kYXJ5LXRpdGxlPkNhbmNlcjwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+Q2FuY2VyPC9h
bHQtdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+Q2FuY2VyPC9mdWxsLXRp
dGxlPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+Q2FuY2VyPC9mdWxs
LXRpdGxlPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjE0OTktNTA2PC9wYWdlcz48dm9sdW1lPjEy
MDwvdm9sdW1lPjxudW1iZXI+MTA8L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+QWR1bHQ8L2tl
eXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5BZ2VkLCA4MCBhbmQgb3Zlcjwv
a2V5d29yZD48a2V5d29yZD4qQ2hlbW9yYWRpb3RoZXJhcHksIEFkanV2YW50PC9rZXl3b3JkPjxr
ZXl3b3JkPkRpc2Vhc2UtRnJlZSBTdXJ2aXZhbDwva2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tl
eXdvcmQ+PGtleXdvcmQ+SGVhZCBhbmQgTmVjayBOZW9wbGFzbXMvKnBhdGhvbG9neS8qc3VyZ2Vy
eS90aGVyYXB5PC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5LYXBs
YW4tTWVpZXIgRXN0aW1hdGU8L2tleXdvcmQ+PGtleXdvcmQ+TGFyeW5nZWFsIE5lb3BsYXNtcy9w
YXRob2xvZ3kvc3VyZ2VyeTwva2V5d29yZD48a2V5d29yZD5MeW1waGF0aWMgTWV0YXN0YXNpczwv
a2V5d29yZD48a2V5d29yZD5NYWxlPC9rZXl3b3JkPjxrZXl3b3JkPk1pZGRsZSBBZ2VkPC9rZXl3
b3JkPjxrZXl3b3JkPk1vdXRoIE5lb3BsYXNtcy9wYXRob2xvZ3kvc3VyZ2VyeTwva2V5d29yZD48
a2V5d29yZD5NdWx0aXZhcmlhdGUgQW5hbHlzaXM8L2tleXdvcmQ+PGtleXdvcmQ+TmVjayBEaXNz
ZWN0aW9uPC9rZXl3b3JkPjxrZXl3b3JkPk5lb3BsYXNtIEdyYWRpbmc8L2tleXdvcmQ+PGtleXdv
cmQ+TmVvcGxhc20gUmVjdXJyZW5jZSwgTG9jYWwvcHJldmVudGlvbiAmYW1wOyBjb250cm9sPC9r
ZXl3b3JkPjxrZXl3b3JkPk5lb3BsYXNtIFN0YWdpbmc8L2tleXdvcmQ+PGtleXdvcmQ+UHJlZGlj
dGl2ZSBWYWx1ZSBvZiBUZXN0czwva2V5d29yZD48a2V5d29yZD5Qcm9nbm9zaXM8L2tleXdvcmQ+
PGtleXdvcmQ+UmlzayBGYWN0b3JzPC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIw
MTQ8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5NYXkgMTU8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRl
cz48aXNibj4xMDk3LTAxNDIgKEVsZWN0cm9uaWMpJiN4RDswMDA4LTU0M1ggKExpbmtpbmcpPC9p
c2JuPjxhY2Nlc3Npb24tbnVtPjI0NTEwNDU0PC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVk
LXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzI0NTEwNDU0PC91
cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDAy
L2NuY3IuMjg1OTY8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0
ZT48QXV0aG9yPkR1bm5lPC9BdXRob3I+PFllYXI+MjAwNjwvWWVhcj48UmVjTnVtPjM5PC9SZWNO
dW0+PHJlY29yZD48cmVjLW51bWJlcj4zOTwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkg
YXBwPSJFTiIgZGItaWQ9Inp3ZHRlOTllc3BmMGVhZTB3c2N2enIwendhNTl3ZmQwdjJ6ZCIgdGlt
ZXN0YW1wPSIxNDc1NzE0OTk3Ij4zOTwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1l
PSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxh
dXRob3I+RHVubmUsIEEuIEEuPC9hdXRob3I+PGF1dGhvcj5NdWxsZXIsIEguIEguPC9hdXRob3I+
PGF1dGhvcj5FaXNlbGUsIEQuIFcuPC9hdXRob3I+PGF1dGhvcj5LZXNzZWwsIEsuPC9hdXRob3I+
PGF1dGhvcj5Nb2xsLCBSLjwvYXV0aG9yPjxhdXRob3I+V2VybmVyLCBKLiBBLjwvYXV0aG9yPjwv
YXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkRlcGFydG1lbnQgb2YgT3RvbGFy
eW5nb2xvZ3ksIEhlYWQgYW5kIE5lY2sgU3VyZ2VyeSwgUGhpbGlwcHMgVW5pdmVyc2l0eSBNYXJi
dXJnLCBEZXV0c2NoaGF1c3N0cmFzc2UgMywgMzUwMzcgTWFyYnVyZywgR2VybWFueS4gZHVlbm5l
QG1lZC51bmktbWFyYnVyZy5kZTwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPk1ldGEtYW5h
bHlzaXMgb2YgdGhlIHByb2dub3N0aWMgc2lnbmlmaWNhbmNlIG9mIHBlcmlub2RhbCBzcHJlYWQg
aW4gaGVhZCBhbmQgbmVjayBzcXVhbW91cyBjZWxsIGNhcmNpbm9tYXMgKEhOU0NDKSBwYXRpZW50
czwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5FdXIgSiBDYW5jZXI8L3NlY29uZGFyeS10aXRsZT48
YWx0LXRpdGxlPkV1cm9wZWFuIGpvdXJuYWwgb2YgY2FuY2VyPC9hbHQtdGl0bGU+PC90aXRsZXM+
PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+RXVyIEogQ2FuY2VyPC9mdWxsLXRpdGxlPjxhYmJyLTE+
RXVyb3BlYW4gam91cm5hbCBvZiBjYW5jZXI8L2FiYnItMT48L3BlcmlvZGljYWw+PGFsdC1wZXJp
b2RpY2FsPjxmdWxsLXRpdGxlPkV1ciBKIENhbmNlcjwvZnVsbC10aXRsZT48YWJici0xPkV1cm9w
ZWFuIGpvdXJuYWwgb2YgY2FuY2VyPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MTg2
My04PC9wYWdlcz48dm9sdW1lPjQyPC92b2x1bWU+PG51bWJlcj4xMjwvbnVtYmVyPjxrZXl3b3Jk
cz48a2V5d29yZD5DYXJjaW5vbWEsIFNxdWFtb3VzIENlbGwvKnBhdGhvbG9neTwva2V5d29yZD48
a2V5d29yZD5IZWFkIGFuZCBOZWNrIE5lb3BsYXNtcy8qcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3
b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5MeW1waGF0aWMgTWV0YXN0YXNpcy9wYXRob2xv
Z3k8L2tleXdvcmQ+PGtleXdvcmQ+T2RkcyBSYXRpbzwva2V5d29yZD48a2V5d29yZD5Qcm9nbm9z
aXM8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAwNjwveWVhcj48cHViLWRhdGVz
PjxkYXRlPkF1ZzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjA5NTktODA0OSAoUHJp
bnQpJiN4RDswOTU5LTgwNDkgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjE2ODMxNTQz
PC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmku
bmxtLm5paC5nb3YvcHVibWVkLzE2ODMxNTQzPC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxl
bGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDE2L2ouZWpjYS4yMDA2LjAxLjA2MjwvZWxlY3Ry
b25pYy1yZXNvdXJjZS1udW0+PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT4A
ADDIN EN.CITE.DATA 12-15 However, pitfalls in the measurement (ie, in larger, matted lymph nodes, in nodes post fine-needle aspiration, and in nodes with near total replacement of lymph node architecture) and the disposition of soft tissue deposits is still not resolved. In general, absence of ENE in a large (greater than 3 cm) lymph node, especially with traversing fibrous bands, should be viewed with skepticism. Soft tissue deposits for lymph node metastases based on limited studies appear to be the equivalent of a positive lymph node with ENE and should be recorded as such.16 However, ENE does not appear to be as prognostically relevant for HPV-mediated/p16-positive and nasopharyngeal cancers. While it may be recorded, it is not required under AJCC guidelines. ADDIN EN.CITE <EndNote><Cite><Author>Lee</Author><Year>2017</Year><RecNum>2</RecNum><DisplayText><style face="superscript">3,4</style></DisplayText><record><rec-number>2</rec-number><foreign-keys><key app="EN" db-id="zwdte99espf0eae0wscvzr0zwa59wfd0v2zd" timestamp="1475711215">2</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author>Lee, A.W.M.</author><author>Lydiatt, W.M.</author><author>Colevas, A.D.</author><author>Glastonbury, C.M.</author><author>Le, Q.T.X.</author><author>O'Sullivan, B</author><author>Weber, R.S.</author><author>Shah, J. P.</author></authors><secondary-authors><author>Amin, M.B.</author></secondary-authors></contributors><titles><title>Nasopharynx</title><secondary-title>AJCC Cancer Staging Manual</secondary-title></titles><edition>8th</edition><dates><year>2017</year></dates><pub-location>New York, NY</pub-location><publisher>Springer</publisher><urls></urls></record></Cite><Cite><Author>O'Sullivan</Author><Year>2017</Year><RecNum>3</RecNum><record><rec-number>3</rec-number><foreign-keys><key app="EN" db-id="zwdte99espf0eae0wscvzr0zwa59wfd0v2zd" timestamp="1475711383">3</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author>O'Sullivan, B.</author><author>Lydiatt, W.M.</author><author>Haughey, B.H.</author><author>Brandwein-Gensler, M. S.</author><author>Glastonbury, C.M.</author><author>Shah, J. P.</author></authors><secondary-authors><author>Amin, M.B.</author></secondary-authors></contributors><titles><title>HPV Mediated (p16+) Oropharyngeal Cancer</title><secondary-title>AJCC Cancer Staging Manual</secondary-title></titles><edition>8th</edition><dates><year>2017</year></dates><pub-location>New York, NY</pub-location><publisher>Springer</publisher><urls></urls></record></Cite></EndNote>17,18References:1.Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004;350(19):1937-1944.2.Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350(19):1945-1952.3.Patel SG, Lydiatt WM, Ridge JA, et al. Cervical lymph nodes and unknown primary tumors of the head and neck. In: Amin MB, ed. AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017.4.Sobin LH, Gospodarowicz MK, Wittekind CH, eds. TNM Classification of Malignant Tumours. New York: Wiley-Liss; 2009.5.Singletary SE, Greene FL, Sobin LH. Classification of isolated tumor cells: clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual. Cancer. 2003;98(12):2740-2741.6.Broglie MA, Haerle SK, Huber GF, Haile SR, Stoeckli SJ. Occult metastases detected by sentinel node biopsy in patients with early oral and oropharyngeal squamous cell carcinomas: Impact on survival. Head Neck. 2013;35(5):660-666.7.Ferlito A, Robbins KT, Shah JP, et al. Proposal for a rational classification of neck dissections. Head Neck. 2011;33(3):445-450.8.Robbins KT, Shaha AR, Medina JE, et al. Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg. 2008;134(5):536-538.9.Seethala RR. Current state of neck dissection in the United States. Head Neck Pathol. 2009;3(3):238-245.10.Suarez C, Rodrigo JP, Robbins KT, et al. Superselective neck dissection: rationale, indications, and results. Eur Arch Otorhinolaryngol. 2013.11.Ebrahimi A, Gil Z, Amit M. International Consortium for Outcome Research (ICOR) in Head and Neck Cancer. Primary tumor staging for oral cancer and a proposed modification incorporating depth of invasion: an international multicenter retrospective study. JAMA Otolaryngol Head Neck Surg. 2014;140(12):1138-1148.12.Ridge JA, Lydiatt WM, Patel SG, et al. Lip and oral cavity. In: Amin MB, ed. AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017.13.Ebrahimi A, Clark JR, Amit M, et al. Minimum nodal yield in oral squamous cell carcinoma: defining the standard of care in a multicenter international pooled validation study. Ann Surg Oncol. 2014;21(9):3049-3055.14.Prabhu RS, Hanasoge S, Magliocca KR, et al. Extent of pathologic extracapsular extension and outcomes in patients with nonoropharyngeal head and neck cancer treated with initial surgical resection. Cancer. 2014;120(10):1499-1506.15.Dunne AA, Muller HH, Eisele DW, Kessel K, Moll R, Werner JA. Meta-analysis of the prognostic significance of perinodal spread in head and neck squamous cell carcinomas (HNSCC) patients. Eur J Cancer. 2006;42(12):1863-1868.16.Jose J, Moor JW, Coatesworth AP, Johnston C, MacLennan K. Soft tissue deposits in neck dissections of patients with head and neck squamous cell carcinoma: prospective analysis of prevalence, survival, and its implications. Arch Otolaryngol Head Neck Surg. 2004;130(2):157-160. 17.O'Sullivan B, Lydiatt WM, Haughey BH, Brandwein-Gensler MS, Glastonbury CM, Shah JP. HPV mediated (p16+) oropharyngeal cancer. In: Amin MB, ed. AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017.18.Lee AWM, Lydiatt WM, Colevas AD, et al. Nasopharynx. In: Amin MB, ed. AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017.H. TNM and Stage GroupingsThe protocol recommends the TNM staging system of the American Joint Committee on Cancer and the International Union Against Cancer for the oropharynx, nasopharynx, and hypopharynx.PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5MZWU8L0F1dGhvcj48WWVhcj4yMDE3PC9ZZWFyPjxSZWNO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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5MZWU8L0F1dGhvcj48WWVhcj4yMDE3PC9ZZWFyPjxSZWNO
dW0+MjwvUmVjTnVtPjxEaXNwbGF5VGV4dD48c3R5bGUgZmFjZT0ic3VwZXJzY3JpcHQiPjItNDwv
c3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjI8L3JlYy1udW1iZXI+PGZv
cmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJ6d2R0ZTk5ZXNwZjBlYWUwd3NjdnpyMHp3
YTU5d2ZkMHYyemQiIHRpbWVzdGFtcD0iMTQ3NTcxMTIxNSI+Mjwva2V5PjwvZm9yZWlnbi1rZXlz
PjxyZWYtdHlwZSBuYW1lPSJCb29rIFNlY3Rpb24iPjU8L3JlZi10eXBlPjxjb250cmlidXRvcnM+
PGF1dGhvcnM+PGF1dGhvcj5MZWUsIEEuVy5NLjwvYXV0aG9yPjxhdXRob3I+THlkaWF0dCwgVy5N
LjwvYXV0aG9yPjxhdXRob3I+Q29sZXZhcywgQS5ELjwvYXV0aG9yPjxhdXRob3I+R2xhc3RvbmJ1
cnksIEMuTS48L2F1dGhvcj48YXV0aG9yPkxlLCBRLlQuWC48L2F1dGhvcj48YXV0aG9yPk8mYXBv
cztTdWxsaXZhbiwgQjwvYXV0aG9yPjxhdXRob3I+V2ViZXIsIFIuUy48L2F1dGhvcj48YXV0aG9y
PlNoYWgsIEouIFAuPC9hdXRob3I+PC9hdXRob3JzPjxzZWNvbmRhcnktYXV0aG9ycz48YXV0aG9y
PkFtaW4sIE0uQi48L2F1dGhvcj48L3NlY29uZGFyeS1hdXRob3JzPjwvY29udHJpYnV0b3JzPjx0
aXRsZXM+PHRpdGxlPk5hc29waGFyeW54PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkFKQ0MgQ2Fu
Y2VyIFN0YWdpbmcgTWFudWFsPC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PGVkaXRpb24+OHRo
PC9lZGl0aW9uPjxkYXRlcz48eWVhcj4yMDE3PC95ZWFyPjwvZGF0ZXM+PHB1Yi1sb2NhdGlvbj5O
ZXcgWW9yaywgTlk8L3B1Yi1sb2NhdGlvbj48cHVibGlzaGVyPlNwcmluZ2VyPC9wdWJsaXNoZXI+
PHVybHM+PC91cmxzPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPkx5ZGlhdHQ8L0F1dGhv
cj48WWVhcj4yMDE3PC9ZZWFyPjxSZWNOdW0+NDwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+
NDwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Inp3ZHRlOTll
c3BmMGVhZTB3c2N2enIwendhNTl3ZmQwdjJ6ZCIgdGltZXN0YW1wPSIxNDc1NzExNDc4Ij40PC9r
ZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkJvb2sgU2VjdGlvbiI+NTwvcmVmLXR5
cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkx5ZGlhdHQsIFcuTS48L2F1dGhvcj48
YXV0aG9yPlJpZGdlLCBKLkEuPC9hdXRob3I+PGF1dGhvcj5QYXRlbCwgUy5HLjwvYXV0aG9yPjxh
dXRob3I+QnJpemVsLCBELk0uPC9hdXRob3I+PGF1dGhvcj5IYXVnaGV5LCBCLkguPC9hdXRob3I+
PGF1dGhvcj5HbGFzdG9uYnVyeSwgQy5NLjwvYXV0aG9yPjxhdXRob3I+QnJhbmR3ZWluLUdlbnNs
ZXIsIE0uIFMuPC9hdXRob3I+PGF1dGhvcj5PJmFwb3M7U3VsbGl2YW4sIEIuPC9hdXRob3I+PGF1
dGhvcj5TaGFoLCBKLiBQLjwvYXV0aG9yPjwvYXV0aG9ycz48c2Vjb25kYXJ5LWF1dGhvcnM+PGF1
dGhvcj5BbWluLCBNLkIuPC9hdXRob3I+PC9zZWNvbmRhcnktYXV0aG9ycz48L2NvbnRyaWJ1dG9y
cz48dGl0bGVzPjx0aXRsZT5Pcm9waGFyeW54IChwMTYgLSkgYW5kIEh5cG9waGFyeW54PC90aXRs
ZT48c2Vjb25kYXJ5LXRpdGxlPkFKQ0MgQ2FuY2VyIFN0YWdpbmcgTWFudWFsPC9zZWNvbmRhcnkt
dGl0bGU+PC90aXRsZXM+PGVkaXRpb24+OHRoPC9lZGl0aW9uPjxkYXRlcz48eWVhcj4yMDE3PC95
ZWFyPjwvZGF0ZXM+PHB1Yi1sb2NhdGlvbj5OZXcgWW9yaywgTlk8L3B1Yi1sb2NhdGlvbj48cHVi
bGlzaGVyPlNwcmluZ2VyPC9wdWJsaXNoZXI+PHVybHM+PC91cmxzPjwvcmVjb3JkPjwvQ2l0ZT48
Q2l0ZT48QXV0aG9yPk8mYXBvcztTdWxsaXZhbjwvQXV0aG9yPjxZZWFyPjIwMTc8L1llYXI+PFJl
Y051bT4zPC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj4zPC9yZWMtbnVtYmVyPjxmb3JlaWdu
LWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iendkdGU5OWVzcGYwZWFlMHdzY3Z6cjB6d2E1OXdm
ZDB2MnpkIiB0aW1lc3RhbXA9IjE0NzU3MTEzODMiPjM8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVm
LXR5cGUgbmFtZT0iQm9vayBTZWN0aW9uIj41PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRo
b3JzPjxhdXRob3I+TyZhcG9zO1N1bGxpdmFuLCBCLjwvYXV0aG9yPjxhdXRob3I+THlkaWF0dCwg
Vy5NLjwvYXV0aG9yPjxhdXRob3I+SGF1Z2hleSwgQi5ILjwvYXV0aG9yPjxhdXRob3I+QnJhbmR3
ZWluLUdlbnNsZXIsIE0uIFMuPC9hdXRob3I+PGF1dGhvcj5HbGFzdG9uYnVyeSwgQy5NLjwvYXV0
aG9yPjxhdXRob3I+U2hhaCwgSi4gUC48L2F1dGhvcj48L2F1dGhvcnM+PHNlY29uZGFyeS1hdXRo
b3JzPjxhdXRob3I+QW1pbiwgTS5CLjwvYXV0aG9yPjwvc2Vjb25kYXJ5LWF1dGhvcnM+PC9jb250
cmlidXRvcnM+PHRpdGxlcz48dGl0bGU+SFBWIE1lZGlhdGVkIChwMTYrKSBPcm9waGFyeW5nZWFs
IENhbmNlcjwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5BSkNDIENhbmNlciBTdGFnaW5nIE1hbnVh
bDwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxlZGl0aW9uPjh0aDwvZWRpdGlvbj48ZGF0ZXM+
PHllYXI+MjAxNzwveWVhcj48L2RhdGVzPjxwdWItbG9jYXRpb24+TmV3IFlvcmssIE5ZPC9wdWIt
bG9jYXRpb24+PHB1Ymxpc2hlcj5TcHJpbmdlcjwvcHVibGlzaGVyPjx1cmxzPjwvdXJscz48L3Jl
Y29yZD48L0NpdGU+PC9FbmROb3RlPn==
ADDIN EN.CITE.DATA 1-3 AJCC 8th edition staging has introduced several changes. Notably HPV-mediated (p16-positive) squamous cell carcinomas of the oropharynx have their own staging system, with respect to both T and N stage. ENE is not relevant to this category and is not incorporated into the N stage. However, ENE is still required for N staging of HPV-unrelated (p16-negative) squamous cell carcinoma and hypopharyngeal carcinomas. For nasopharyngeal carcinomas, T stage has been revised. The extent of structural involvement for T2 and T4 in particular have been redefined. T2 denotes tumors with extension to parapharyngeal space and/or adjacent soft tissue involvement (medial pterygoid, lateral pterygoid, prevertebral muscles). T4 indicates tumor with intracranial extension, involvement of cranial nerves, hypopharynx, orbit, parotid gland, and/or extensive soft tissue infiltration beyond the lateral surface of the lateral pterygoid muscle. Additionally, N stage for nasopharyngeal squamous cell carcinoma has been simplified, removing N3a and N3b substratification. The anatomic border for defining N3 has been revised from supraclavicular fossa (Level VB) to caudal border of the cricoid cartilage (Level IV, and VB). T and N anatomic definitions are summarized in Figure 3.Figure 3. Differences in defining criteria between the 7th edition and the 8th edition for staging of NPC: (A) changing the extent of soft tissue involvement as T2 and T4 criteria. Abbreviations: CS = carotid space, LP = lateral pterygoid muscle, M = masseter muscle, MP = medial pterygoid muscle, PG = parotid gland, PPS = parapharyngeal space, PV = prevertebral muscle, T = temporalis muscle; (B) replacing supraclavicular fossa (blue) by lower neck, ie, below caudal border of cricoid cartilage (red) as N3 criteria.PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5QYW48L0F1dGhvcj48WWVhcj4yMDE1PC9ZZWFyPjxSZWNO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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5QYW48L0F1dGhvcj48WWVhcj4yMDE1PC9ZZWFyPjxSZWNO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ADDIN EN.CITE.DATA 4 From AJCC Cancer Staging Manual. 8th ed. New York: Springer; 2017. ? American Joint Committee on Cancer. Reproduced with permission.The 8th edition of the AJCC staging of head and neck cancers includes mucosal melanomas; this does not show significant changes from the 7th edition. Approximately two-thirds of mucosal melanomas arise in the sinonasal tract, one-quarter are found in the oral cavity, and the remainder occur only sporadically in other mucosal sites of the head and neck. Even small cancers behave aggressively with high rates of recurrence and death. To reflect this aggressive behavior, primary cancers limited to the mucosa are considered T3 lesions. Advanced mucosal melanomas are classified as T4a and T4b. The anatomic extent criteria to define moderately advanced (T4a) and very advanced (T4b) disease are given below. The AJCC staging for mucosal melanomas does not provide for the histologic definition of a T3 lesion; as the majority of mucosal melanomas are invasive at presentation, mucosal-based melanomas (T3 lesions) include those lesions that involve either the epithelium and/or lamina propria of the involved site. Rare examples of in situ mucosal melanomas occur, but in situ mucosal melanomas are excluded from staging, as they are extremely rare.5 Carcinomas of minor salivary glands of the upper aerodigestive tract site, including the oral cavity, are staged according to schemes corresponding to the anatomic site of occurrence. There is no currently accepted staging for central (primary intraosseous) salivary gland tumors.By AJCC/UICC convention, the designation “T” refers to a primary tumor that has not been previously treated. The symbol “p” refers to the pathologic classification of the TNM, as opposed to the clinical classification, and is based on clinical stage information supplemented/modified by operative findings and gross and microscopic evaluation of the resected specimens. ADDIN EN.CITE <EndNote><Cite><Author>Gress</Author><Year>2017</Year><RecNum>1</RecNum><DisplayText><style face="superscript">1</style></DisplayText><record><rec-number>1</rec-number><foreign-keys><key app="EN" db-id="zwdte99espf0eae0wscvzr0zwa59wfd0v2zd" timestamp="1475711114">1</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author>Gress,D.M. </author><author>Edge, S.B.</author><author>Greene, F.L.</author><author>Washington, M.K.</author><author>Asare, E.A.</author><author>Brierley, J.D.</author><author>Byrd, D.R.</author><author>Compton, C.C.</author><author>Jessup, J.M.</author><author>Winchester, D.P</author><author>Amin, M.B.</author><author>Gershenwald, J.E.</author></authors><secondary-authors><author>Amin, M.B.</author></secondary-authors></contributors><titles><title>Principles of cancer staging</title><secondary-title>AJCC Cancer Staging Manual</secondary-title></titles><edition>8th</edition><dates><year>2017</year></dates><pub-location>New York, NY</pub-location><publisher>Springer</publisher><urls></urls></record></Cite></EndNote>1 pT entails a resection of the primary tumor or biopsy adequate to evaluate the highest pT category, pN entails removal of nodes adequate to validate lymph node metastasis, and pM implies microscopic examination of distant lesions. Clinical classification (cTNM) is usually carried out by the referring physician before treatment during initial evaluation of the patient or when pathologic classification is not possible.Pathologic staging is usually performed after surgical resection of the primary tumor. Pathologic staging depends on pathologic documentation of the anatomic extent of disease, whether or not the primary tumor has been completely removed. If a biopsied tumor is not resected for any reason (eg, when technically unfeasible) and if the highest T and N categories or the M1 category of the tumor can be confirmed microscopically, the criteria for pathologic classification and staging have been satisfied without total removal of the primary cancer.TNM DescriptorsFor identification of special cases of TNM or pTNM classifications, the “m” suffix and “y” and “r” prefixes are used. Although they do not affect the stage grouping, they indicate cases needing separate analysis.The “m” suffix indicates the presence of multiple primary tumors in a single site and is recorded in parentheses: pT(m)NM.The “y” prefix indicates those cases in which classification is performed during or following initial multimodality therapy (ie, neoadjuvant chemotherapy, radiation therapy, or both chemotherapy and radiation therapy). The cTNM or pTNM category is identified by a “y” prefix. The ycTNM or ypTNM categorizes the extent of tumor actually present at the time of that examination. The “y” categorization is not an estimate of tumor prior to multimodality therapy (ie, before initiation of neoadjuvant therapy).The “r” prefix indicates a recurrent tumor when staged after a documented disease-free interval, and is identified by the “r” prefix: rTNM.Additional DescriptorsResidual Tumor (R)Tumor remaining in a patient after therapy with curative intent (eg, surgical resection for cure) is categorized by a system known as R classification, shown below.RXPresence of residual tumor cannot be assessedR0No residual tumorR1Microscopic residual tumorR2Macroscopic residual tumorFor the surgeon, the R classification may be useful to indicate the known or assumed status of the completeness of a surgical excision. For the pathologist, the R classification is relevant to the status of the margins of a surgical resection specimen. That is, tumor involving the resection margin on pathologic examination may be assumed to correspond to residual tumor in the patient and may be classified as macroscopic or microscopic according to the findings at the specimen margin(s).References:1.Lydiatt WM, Ridge JA, Patel SG, et al. Oropharynx (p16 -) and hypopharynx. In: Amin MB, ed. AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017.2.O'Sullivan B, Lydiatt WM, Haughey BH, Brandwein-Gensler MS, Glastonbury CM, Shah JP. HPV mediated (p16+) oropharyngeal cancer. In: Amin MB, ed. AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017.3.Lee AWM, Lydiatt WM, Colevas AD, et al. Nasopharynx. In: Amin MB, ed. AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017.4.Pan JJ, Ng WT, Zong JF, et al. Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy. Cancer. 2015;122(4):546-558.5.Lydiatt WM, Brandwein-Gensler MS, Kraus DH, Mukherji SK, Ridge JA, Shah JP. Mucosal melanoma of the head and neck. In: Amin MB, ed. AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017.I. Dysplasia of the Upper Aerodigestive Tract (UADT)The concept of epithelial precursor lesions, including dysplasia and carcinoma in situ of the oropharyngeal (base of tongue and tonsils) and nasopharyngeal mucosa, are not well defined. In biopsies of nasopharyngeal carcinoma, only a minority of cases (less than 10%) will have an in situ component.1 Further, carcinoma in situ of the oropharynx and nasopharynx as confirmed by biopsy to rule out an invasive carcinoma component is very rare. Histologically, carcinoma in situ of the oropharynx and nasopharynx may be confined to the surface or crypt epithelium without invasive carcinoma and, when present, are most often of the nonkeratinizing type. Hypopharyngeal precursor lesions are rarely identified as hypopharyngeal cancers by virtue of their anatomic site and often remain clinically quiescent commonly presenting as invasive carcinomas. References:1.Chan JKC, Pilch BZ, Bray F, et al. Nasopharyngeal carcinoma. In: Barnes L, Eveson JW, Reichart P, Sidransky D, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Head and Neck Tumours. Lyon, France: IARC; 2005:85-97. ................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- appendix i lymph node lymph node chain
- unexplained lymphadenopathy evaluation and
- neck dissection techniques and complications
- the size of lymph nodes in the neck on sonograms
- us neck lymph node survey ut southwestern
- tnm staging of head and neck cancer and neck
- head and neck
- thyroid case scenarios naaccr
- base of tongue 2019 texas department of state health
- cap cancer protocol major salivary glands
Related searches
- aip protocol food list printable
- betadine protocol viral conjunctivitis
- aip protocol food list
- autoimmune protocol diet print out
- autoimmune protocol food list
- sample protocol template
- time out protocol in surgery
- crps physical therapy protocol pdf
- joint commission universal protocol checklist
- universal protocol standard
- universal protocol checklist
- joint commission protocol orders